Today

Agents

Chat

Arena

Discover

More

App

Revvity Q2 Adjusted EPS USD 1.41 Vs. IBES Estimate USD 1.22 - RVTY News | Rallies

Revvity Q2 Adjusted EPS USD 1.41 Vs. IBES Estimate USD 1.22

RVTY•2026-08-04

Revvity reports second-quarter results above estimates

Aug 04 (Reuters) - Revvity Q2 revenue USD 730 million vs. IBES estimate USD 709.1 million.

Q2 adjusted EPS continuing operations USD 1.41

Related News

Sharon AI signs US$373 million five-year AI cloud services agreement

SHAZ•2026-08-04

iBio names endocrinologist Molly Carr as chief medical officer

IBIO•2026-08-04

USA Compression Q2 revenue beats on fleet expansion, higher pricing

USAC•2026-08-04

B

Germany's BioNTech Q2 revenue drops 60% on lower COVID-19 vaccine demand

BNTX•2026-08-04

Integer Holdings Corp <ITGR.N>: Truist Securities cuts to hold from buy; raises target price to $127 from $110

ITGR•2026-08-04